Trial intelligence / Profile preview

Calcium Carbonate to Augment Labor Contractions

NCT06580782Phase 4Recruiting

Sponsor
Weill Cornell Medicine
Start
Nov 2024
Primary completion
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of calcium carbonate in labor dystocia (2 arms), sponsored by Weill Cornell Medicine. Primary endpoints: Number of Participants Consented at Day 0, Number of Participants Enrolled at Day 0 and 1 more. Started Nov 2024; status: recruiting.

02

Drugs

calcium carbonate
03

Conditions

labor dystocia

Beyond the preview

Go deeper on NCT06580782.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06580782.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call